Patents by Inventor Scott C. Fahrenkrug

Scott C. Fahrenkrug has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240057570
    Abstract: Methods, uses, and animals for introgression of alleles between animals, including SNPs. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell with a mismatch in the binding of the targeting endonuclease and the targeted site.
    Type: Application
    Filed: September 19, 2022
    Publication date: February 22, 2024
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Patent number: 11477969
    Abstract: Methods, uses, and animals for introgression of alleles between animals, including SNPs. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell with a mismatch in the binding of the targeting endonuclease and the targeted site.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: October 25, 2022
    Assignee: Recombinetics, Inc.
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20220056482
    Abstract: The present disclosure relates to methods for making genetic edits in vitro in a non-human vertebrate cell or embryo at a plurality of target chromosomal DNA sites. Methods for making a non-human animal having multiplex genetic edits at a plurality of target chromosomal DNA sites and making a non-human vertebrate animal chimeric for host cells and donor cells are also considered.
    Type: Application
    Filed: July 19, 2021
    Publication date: February 24, 2022
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20210185990
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Application
    Filed: December 10, 2020
    Publication date: June 24, 2021
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Patent number: 10959414
    Abstract: Methods, uses, and animals for introgression of alleles between animals, including SNPs. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell with a mismatch in the binding of the targeting endonuclease and the targeted site.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: March 30, 2021
    Assignee: Recombinetics, Inc.
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Patent number: 10959415
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: March 30, 2021
    Assignee: Recombinetics, Inc.
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Patent number: 10920242
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: February 16, 2021
    Assignee: Recombinetics, Inc.
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Patent number: 10893667
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: January 19, 2021
    Assignee: Recombinetics, Inc.
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20200017878
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 16, 2020
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20200017882
    Abstract: Human or humanized tissues and organs suitable for transplant are disclosed herein. Gene editing of a host animal provides a niche for complementation of the missing genetic information by donor stem cells. Editing of a host genome to knock out or disrupt genes responsible for the growth and/or differentiation of a target organ and injecting that animal at an embryo stage with donor stem cells to complement the missing genetic information for the growth and development of the organ. The result is a chimeric animal in which the complemented tissue (human/humanized organ) matches the genotype and phenotype of the donor. Such organs may be made in a single generation and the stem cell may be taken or generated from the patient's own body. As disclosed herein, it is possible to do so by simultaneously editing multiple genes in a cell or embryo creating a “niche” for the complemented tissue.
    Type: Application
    Filed: April 16, 2019
    Publication date: January 16, 2020
    Inventors: Scott C. Fahrenkrug, Laurence Cooper, Perry B. Hackett, Daniel F. Carlson
  • Publication number: 20200017877
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 16, 2020
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20190335725
    Abstract: A genetically modified livestock animal, and methods of making and using the same, the animal comprising a genetic modification to disrupt a target gene selectively involved in gametogenesis, wherein the disruption of the target gene prevents formation of functional gametes of the animal. Animals that create progeny with donor genetics, and methods of making and using the same. Cells, and methods of making and using the cells, with a genetic modification to disrupt a target gene selectively involved in gametogenesis.
    Type: Application
    Filed: June 3, 2019
    Publication date: November 7, 2019
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20190323031
    Abstract: Methods, uses, and compositions for manipulating genomic DNA. Some of the embodiments of the invention provide for making a founder animal that is completely free of all unplanned genetic modifications. Some embodiments are directed to removing genetic faults in established breeds without making other alterations to the genome. Other embodiments are directed to particular tools or processes such as TALENs or CRISPR with a preferred truncation. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell (optionally with a mismatch in the binding of the targeting endonuclease and the targeted site). Another embodiment includes processes of making a genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature.
    Type: Application
    Filed: May 28, 2019
    Publication date: October 24, 2019
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20190254266
    Abstract: Human or humanized tissues and organs suitable for transplant are disclosed herein. Gene editing of a host animal provides a niche for complementation of the missing genetic information by donor stem cells. Editing of a host genome to knock out or debilitate genes responsible for the growth and/or differentiation of a target organ and injecting that animal at an embryo stage with donor stem cells to complement the missing genetic information for the growth and development of the organ. The result is a chimeric animal in which the complemented tissue (human/humanized organ) matches the genotype and phenotype of the donor. Such organs may be made in a single generation and the stem cell may be taken or generated from the patient's own body. As disclosed herein, it is possible to do so by simultaneously editing multiple genes in a cell or embryo creating a “niche” for the complemented tissue.
    Type: Application
    Filed: October 27, 2016
    Publication date: August 22, 2019
    Applicants: Regents of the University of Minnesota, Recombinetics, Inc., Board of Regents of the University of Texas System
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson, Peter Igarashi, Thomas Carroll
  • Publication number: 20190223417
    Abstract: Disclosed herein are genomically modified livestock animals and methods to provide them that express the SLICK phenotype. The animals disclosed herein express a truncated allele for the prolactin receptor (PRLR) gene. When expressed, the livestock animals produce a PRLR that is missing up to the terminal 148 amino acid (aa) residues of the protein all ranges and values within the explicitly stated range are contemplated: e.g., from 148 to 69. Animals expressing SLICK have superior thermoregulatory ability compared to non-slick animals and experience a less drastic depression in milk yield during the summer.
    Type: Application
    Filed: February 21, 2019
    Publication date: July 25, 2019
    Inventors: Tad S. Sonstegard, Daniel F. Carlson, Scott C. Fahrenkrug
  • Publication number: 20190194687
    Abstract: Methods, uses, and animals for introgression of alleles between animals, including SNPs. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell with a mismatch in the binding of the targeting endonuclease and the targeted site.
    Type: Application
    Filed: March 6, 2019
    Publication date: June 27, 2019
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson, Tad S. Sonstegard
  • Publication number: 20190106708
    Abstract: Methods, uses, and animals for introgression of alleles between animals, including SNPs. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell with a mismatch in the binding of the targeting endonuclease and the targeted site.
    Type: Application
    Filed: September 20, 2018
    Publication date: April 11, 2019
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson
  • Publication number: 20180310536
    Abstract: A genetically modified livestock animal comprising a genomic modification to an eIF4G gene. Cells, genes, and proteins encompassing a protease-resistant eIF4G protein or gene.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 1, 2018
    Inventors: Daniel F. Carlson, Scott C. Fahrenkrug
  • Patent number: 10058078
    Abstract: A genetically modified livestock animal comprising a genomic modification to an eIF4G gene. Cells, genes, and proteins encompassing a protease-resistant eIF4G protein or gene.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 28, 2018
    Assignee: RECOMBINETICS, INC.
    Inventors: Daniel F. Carlson, Scott C. Fahrenkrug
  • Publication number: 20180235194
    Abstract: Materials and methods for making multiplex gene edits in cells and are presented. Further methods include animals and methods of making the same. Methods of making chimeric animals are presented, as well as chimeric animals.
    Type: Application
    Filed: March 16, 2018
    Publication date: August 23, 2018
    Inventors: Scott C. Fahrenkrug, Daniel F. Carlson